Baricitinib Maintains Established Safety Profile - MD Magazine

Baricitinib Maintains Established Safety Profile  MD Magazine

Assorted trials and a long-term exposure study of 3770 patients with rheumatoid arthritis further demonstrate baricitinib's previously recorded safety profile.



Comments

Popular posts from this blog

Epidemiology and prevention of venous thromboembolism